MAC Cosmetics: Changing Lives One Lipstick at a Time

NORTHAMPTON, MA / ACCESSWIRE / November 1, 2023 / M·A·C Cosmetics / In 1994, M·A·C founders Frank Toskan and the late Frank Angelo created the VIVA GLAM Lipstick in response to the HIV/AIDS epidemic directly impacting their community. They donated 100% of the selling price to organizations serving people impacted by HIV/AIDS. Thanks to this powerful mission, VIVA GLAM has raised over $520 million USD and helps more than 19 million people globally each year.

As M·A·C embarks on its 40th anniversary in 2024, it plans to elevate VIVA GLAM to become the brand's all-encompassing purpose platform centered around equality for everyone - while continuing its longstanding support for people impacted by HIV/AIDS.

As it looks to the future, the brand is also reimagining the pioneer Back-To-M∙A∙C consumer takeback program, which was created 33 years ago to create a place for makeup packaging in the circular economy. In the past year alone, more than 176,000 pounds of empty containers have been processed in Canada, where the brand was born. That's the equivalent of 4.8 million lipsticks. M∙A∙C continues to find new ways to improve and scale the program through new recycling partners around the world and recently formed a partnership with Plastics for Change, a trusted source of fair-trade verified recycled plastic to help reduce plastic waste while improving communities.

Learn more about M∙A∙C's commitment to leveraging the power of community to transform society at: https://www.maccosmetics.com/mac-cares

View additional multimedia and more ESG storytelling from M·A·C Cosmetics on 3blmedia.com.

Contact Info:
Spokesperson: M·A·C Cosmetics
Website: https://www.3blmedia.com/profiles/mac-cosmetics
Email: [email protected]

SOURCE: M·A·C Cosmetics

You May Also Be Interested In

• Menos AI Surpasses $10 Million in Total Funding as Copper Sky Capital Doubles Down
• Currus Biologics announces FDA IND clearance for Phase 1 trial of CUR-001 in mesothelin-positive advanced refractory solid tumours
• Companies From Uranium Mining to Fusion Meet Institutional Investors at the Inaugural ROTH Emerging Nuclear Technology Conference